Published in AIDS Weekly, September 21st, 1998
The finding, reported in the August 1998 issue of Nature Medicine, focused specifically on cytomegalovirus (CMV), the leading cause of blindness in people with AIDS. But the researchers said the study may help to clarify an ongoing question in HIV treatment: Do the CD4+ T cells that are replenished by the immune system after highly active antiretroviral therapy (HAART) create the pathogen-specific responses needed to combat the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.